Vishal Bali and Asia Healthcare Holdings: How to Give Doctors Ownership the Law Won't Allow
Inside the single-specialty hospital platform spanning roughly 75 cities, where phantom stock, the 35 percent rule, and liquidity boxes do the job ESOPs cannot.
Picture the clinician who has spent fifteen years building a hospital around their own name. One day they hand majority control to an outside platform and walk out with a minority stake and a wider smile than the cheque alone explains. Hand over control and motivation usually leaves with it. Yet in single-specialty healthcare this trade happens again and again, and the people who make it tend to come out wealthier.
The man across the table is often Vishal Bali, Executive Chairman of Asia Healthcare Holdings (AHH). He has earned the right to break the rules others follow. He grew Wockhardt Hospitals from a single hospital into a national chain, led its merger into Fortis, and ran Fortis as Group CEO when it spanned roughly 68 hospitals across 12 countries and more than 20,000 people. Since 2016 he has been building something quieter and, by footprint, larger. Start with the contradiction at its center: in Indian healthcare, the most valuable people are exactly the ones you cannot legally give equity to.
Check out the video of the conversation here or read on for insights.
The footprint hiding in plain sight
The instinct is to assume the giant multi-specialty chains own the map. The numbers say otherwise.
Our own ecosystem today operates in 75 cities in the country. That has all happened over ten years, whereas the large-format enterprises have been there for 30 or 40 years.
The reason is structural, and it comes down to how many senior doctors a unit needs. A single-specialty hospital runs on three to six full-time anchor clinicians. A multi-specialty hospital needs around 60, because every department demands its own senior consultant. Fewer anchors per unit means each new city is cheaper and faster to open, which is how a focused chain out-spreads a sprawling one.
That focus has produced real scale. AHH runs Motherhood Hospitals in mother and child care, the Asian Institute of Nephrology and Urology, positioned as India’s only dedicated urology and nephrology network, and Nova IVF in fertility. Nova is the clearest proof of the model: when AHH acquired it in 2019 it had 19 centres. It has since crossed 100 centres across roughly 70 cities, with more than half of recent openings in Tier-2 and Tier-3 towns. The capital behind this is patient, not speculative. AHH was incubated by TPG Growth in 2016 and is backed by Singapore’s sovereign wealth fund GIC, which put in US$170 million in 2022 and a further US$150 million in December 2024. Across its chains, AHH has deployed roughly US$300 million.
The people who will not be employees
Here the conventional playbook breaks. In most industries the prize for commitment is equity, and the vehicle is an ESOP. But under India’s Companies Act, ESOPs can go only to permanent employees and directors, not to consultants. And the best doctors, almost as a matter of identity, refuse to become employees.
What is changing is not their status but their exclusivity. Vishal is precise about the line.
The shift will not happen from them being consultants to employees. The shift is happening from a visiting model to a full-time model. While they continue to be a consultant in the contractual structure, they are committed 100 percent to you.
So the question becomes how to make a non-employee feel like an owner. The answer is a stack of instruments the ESOP rulebook never contemplated: phantom stock and stock appreciation rights, which pay cash tracking the share value without issuing a share; fully convertible debentures, which turn debt into equity at a set milestone; and retainers priced above what a clinician currently bills, so the overpayment itself becomes the lock-in. The audience for this is far wider than hospitals. Any founder leaning on fractional executives or expert consultants hits the same wall, and the same workaround applies. Host Satish Mugulavalli put the underlying tension in a single line:
I would love to own 2 percent of the company that I work for.
The catch is that doctors do not respond the way founders expect. Offered upside in place of cash, they tend to want both.
It’s actually the other way around. Increase my retainer, plus give me something else too.
And the deepest insight here is cultural, not financial. Ownership changes how a person thinks about the enterprise, and its absence changes it just as much.
In an ESOP program you never think like that. But under the clinical ecosystem, they start thinking it’s my practice and my unit, and that governs everything on the economic side for me.
That is why Vishal layers unit economics underneath enterprise upside. A clinician who lives and breathes their own hospital wants a share of that hospital first and a piece of the platform second. Reverse the order and the incentive misfires.
The 35 percent rule and the outsider hire
The other place AHH departs from convention is the acquisition itself. The standard assumption is that getting bought means cashing out and drifting away. Vishal engineers the opposite.
I prefer that they always remain at 30 or 35 percent. In two of our enterprises, that 35 percent has come down to 10 or 12 percent over time, and they see exponential value creation from there.
It is a smaller slice of a bigger pie, and the arithmetic tends to favour the founder: a diluted minority stake in a fast-growing, professionally run platform can be worth more than the whole company was at the point of sale. To stop founders waiting years for an IPO to feel any of that, AHH builds what Vishal calls liquidity boxes, pre-agreed windows to take money off the table before the listing. He is also clear about who carries the risk, which is part of why founders sign.
If we put mediocre talent to work and the enterprises don’t really change, then the fault is ours and not theirs.
For a business this clinical, the org chart is short on clinicians, by design.
My CFO comes from the edtech world. The marketing guys are from FMCG. The B2B sales teams are coming from the insurance world.
The logic is that domain expertise, left alone too long, stagnates a sector, and fresh DNA unsticks it. A soap-brand marketer selling IVF sounds like a category error until you notice that IVF and maternity are consumer choices, made by couples picking a brand, which is exactly what FMCG marketers know how to win. The rule of thumb travels well beyond healthcare: hire the functional expert over the domain expert when the domain has stopped evolving.
The problem the playbook cannot solve
Vishal does not end on the wins. The limit of the model is people, specifically the nursing and paramedical workforce. Buildings are the easy part.
Real estate is not an issue. We can start building beds anywhere. But the biggest issue we face today is the ancillary staff.
By his account, nursing attrition runs at 30 to 40 percent, churning frontline staff roughly every eighteen months. He calls it a self-created problem for the country, rooted in shuttered nursing colleges, the overseas pull, and a culture failure as much as a pay gap: nurses leave because abroad their work is respected in a way the hospital floor at home does not reliably offer. For any operator running a high-churn frontline team, the lesson holds. Pay is one lever; respect and aspiration are the ones that move retention.
It is also the live question hanging over everything else. AHH is still private, and the unified-cap-table listing Vishal points to in the next one to two years is the moment when phantom-stock and FCD holders convert belief into realised value. That finish line is the real engine of loyalty here, and it explains the clinician from the opening scene. Ownership, it turns out, is not a single instrument but a design problem, and the founders who solve it get to keep their best people without ever putting them on the payroll.
Listen now!
Other ways to listen:
Until next time,
Your Host,
Satish Mugulavalli